Forward PE Ratio: 39.42

Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.

The forward PE ratio is 39.42.

Forward PE Ratio (39.42) = Close Price ($380.03) / Consensus Forward EPS ($9.64)

BIO Forward PE Ratio Metrics

Trailing vs Forward

The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $9.64 implies +16.8% EPS growth vs the reported trailing $8.25.

At today's $380.03 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.

Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.

Forward PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Forward PE Ratio FAQ

What is the forward PE ratio for Bio-Rad Laboratories, Inc. (BIO)?

The forward PE ratio for BIO stock is 39.42.

Related Metrics